• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/38

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

38 Cards in this Set

  • Front
  • Back
MS prevalance
Northern NE

Much more common in women
Genetic predisp of MS
DR2 predominant.
Relapsing-remitting MS
Most common.

Attack, disability, return almost to baseline, repeat.
Secondary progressive MS
Second most common

After disability, basically no return to a baseline. But it stays there for a while.

So it gets worse much quicker the RRMS.
Primary progressive MS
Later onset, male dominant.

Patient just gradually gets worse and worse.
Progressive relapsing MS
After disability, It goes back to baseline but then gradually gets worse. Then there is a quick jump up in disability. Repeat.
Dx of MS - general
Easily missed, must be thinking about it.

Also it is kinda treatable, so early detection is critical.
What is an MS attack?
This is what causes the disability.

Can be subjective (e.g. change in sensory) or objective (strange gait, vision change, etc.)

24 hour duration minimum

Must be 30 day gap between attacks.
Psuedoattack
not a true MS attack

It lasts less than 24 hours.
Pathophys of MS
T cell activated and upregulated Alpha-4-beta-1. This recognizes VCAM on BBB and chemokines are secreted to allow metalloproteinases to break BBB and let T cell in.

The T cell is then reactivated in CNS (most likely by a B cell) and then NO eventually causes demyelination.
Common clincial sx of MS
Fatigue (due to IL-6 - just like in CA)
Numbness
Optic Neuritis
Weakness (hemiparesis or transverse myelitis)
Diplopia
Poor coordination (gait ataxia, dysmetria)
Short-term memory loss (executive functions)
Depression and sexual dysfunction
Bladder and bowel dysfunction
Slurred speech

IT IS ALSO A DISEASE OF GRAY MATTER!!!
Time/space dissemination
Two neuro events must be separated by 30 days and two anatomic events must be confirmed (e.g. optic neuritis and leg parasthesia).
Dx criteria of MS
Often a dx of exclusion

Not due to another disease (lupud, thyroid, B12, Lyme, etc.)

Time/space dissemination

Positive MRI
3 categories of MS dx
Clinically defined - all criteria met

Probable - All criteria met except only one objective change on exam despite two symptomatic episodes or one symptomatic episode and 2+ objective changes.

At risk for MS - all criteria met except only 1 symptomative and 1 objective finding on exam. Or it is a clinically isolated syndrome (a 1 time neurological episode)
MRI - T1
ASSESSMENT OF THE DEGEN PROCESS

Assess black holes and atrophies determined by brain paraenchymal fraction. This is ebcasue inflammation over time causes holes in the brain near the ventricles and they fuse together to reduce brain mass.
MRI - T2
ASSESS INFLAMMATORY PROCESS

AKA FLAIR-assess disease burden.
MRI - T1 plus gadolinium
Assess recent events disrupting BBB. To tell if it is active within past 2-4 weeks.
Upwards extensions on sagittal view of MRI (from corpus callosum)
Dawson's fingers

very characteristic of MS.
Positive MRI for MS
3/4:

1 gadolinium enhancing CNS lesion or 9 T2 (or FLAIR) hyperintensities

1 or more cord/infratentorial lesion

1 or more juxtacortical lesion

3 or more paraventricular lesions.
2 other lab studies to confirm MS
Positive CSF - oligoclonal IgG bands in CSF, and not in serum. (this is bc there are b cell germinal centers in brains of MS patients. Must also have low cellularity)

Positive VER - (visual evoked response) - Asymm. in time for optic nerve signal to get to back of brain - signals demyelination. Wave form will be delayed but well preserved.
2 parts of MS
1st part - inflammatory

2nd part - degenerative
What happens to axons in MS?
Transected (cut) - independent of areas of inflammation.
MS is an ____ disease
immunological!

(remember, ventricles will expand dramatically)
Pro-inflammatory and neurotoxic factors
IL-17,2
Th1 cytokines
TNF alpha
NO
ROS
glutamate
Abs and complement
cell-mediated neurotoxicity.
Anti-inflammatory and neuroprot. factors
Th2
TGF-beta
IL-10
Neurotrophic factors (BDNF, NGF, NT-3, CNTF, GDNF)
Tregs in MS
Dysfunctional. Missing foxp3.
BDNF levels in MS
increase during relapses and recovery to repair damaged tissue.

Dramatic increase near MS lesions.
IFN-beta
All injections

Avonex (lose dose - once per week)

Betaseron (every other day - "qod") or Rebif (3x per week)

This is pro-inflammatory normally, but at high levels it turns itself off.

Used in tx of relapsing MS.

For RRMS
Glatiramer acetate (Copaxone)
For RRMS or clinically isolated syndrome

It is random AAs that is the core of myelin basic protein. Shifts to a Th2 response and assists TRegs.
Natalizumab (Tysabri)
RRMS
Antibody to alpha-4-beta-1 so T cells can't cross BBB.

Also used for Crohn's disease.

Can cause bad infections
Mitoxantrone
For secondary progressive MS. A chemo agent.
IFN beta mech of action
Downreg matrix metalloproteinases (they break BBB) and make more soluble VCAM receptor (to outcompete the VCAM on BBB). Also downreg IL-12 (key to autoimmune diseases).

This decreases Gd enhancing activity (less BBB instability) and promotes neuroprotection
Glatiramer acetat (Copraxone)e mech of action
Induces TH2 shift.

Neuroprotection
Interferon SE
Flulike sx, leukopenia, high LFTs
glatiramer acetate (Copaxone) SE
Injection site rxn and chest pain.
Mitoxantrone SE
Want to use it sparingly bc it is a chemo agent. Cardio toxicity and leukopenia. and N/V
Natalizumab (Tysabri) SE
Opportunistic infections and survival of tumor cells.
MS - whole brain phenomena - other sx
weakness, spasticity, pain, depression, bladder